In Today’s News

New Amazon Crisis Could Tank U.S. Stock Market [sponsor]

Fitch downgrades Aston Martin’s ratings as US demand uncertain

WASHINGTON (Reuters) -Credit rating agency Fitch Ratings has downgraded British automaker Aston Martin’s debt ratings, citing the luxury sports car maker’s persistent negative cash flow and uncertainty around its U.S. customer base.In a Thursday report, Fitch analysts noted Aston Martin’s sales fell 17% year …

Why Are Renowned Billionaires Investing in This Gold Mining Opportunity? [sponsor]
Prominent figures in the gold industry—Eric Sprott, Goldcorp founder Rob McEwen, and Kinross founder Bob Buchan—each hold significant shares in a small Nevada gold mining venture. What’s driving their interest? This company is already extracting gold, boasts substantial infrastructure, and is located in one of the globe’s most prolific gold mining regions. When billionaires take early positions, there’s a compelling reason behind it. Discover why these gold titans are supporting a firm still priced under $1

Fed hopes melt, stocks sink

ORLANDO, Florida (Reuters) -Wall Street tumbled and Treasury yields rose on Thursday as expectations of a Federal Reserve interest rate cut next month faded rapidly, while the dollar also fell in a bleak session for U.S. asset prices.More on that below. In my column today I look at the emerging parallels betw …

Is Big Pharma’s Next Target Already in Motion? [sponsor]
A groundbreaking biotech firm has potentially solved one of medicine’s most significant challenges—delivering cancer therapeutics in a safe and effective manner. With proprietary technology and promising preliminary results, it is already drawing the interest of major pharmaceutical companies. Discover which biotech is poised to become a key player for Big Pharma

Pfizer slashes stake in COVID vaccine partner BioNTech

This marks a strategic shift after Pfizer and BioNTech began their partnership in 2018, collaborating on the development of mRNA-based influenza vaccines. Their relationship intensified in early 2020 as the COVID pandemic unfolded, when the two companies joined forces to create the world’s first authorized mR …

The Next AI Revolution Isn’t About Chips. It’s About Software – And This Startup Is At The Forefront. [sponsor]
The initial AI boom catapulted chip manufacturers like Nvidia and Super Micro to incredible heights. Now, AI 2.0 is focused on software, and RAD Intel is spearheading this movement. Their innovative platform leverages AI to assist brands in pinpointing the ideal audience and crafting the precise content to spur action. Already a trusted partner of numerous Fortune 1000 brands and leading global agencies, RAD Intel has established recurring seven-figure collaborations. With backing from Adobe and Fidelity Ventures, they are tackling a staggering $1.3 trillion challenge at the heart of marketing inefficiency. What’s even more exciting? They’re offering shares at just $0.81 through a Reg A round. The next breakout company in AI won’t be a chipmaker; it will be the entity revolutionizing how AI is implemented at scale – and that’s RAD Intel. Want to get in before the market catches on? Act quickly – the share price is set to rise soon! Secure your shares at $0.81 before the deadline on Nov 20! *DISCLOSURE: This is a paid advertisement for RAD Intel’s Reg A offering and involves risk, including the potential loss of principal. Please review the offering circular and related risks at invest.radintel.ai. *This valuation has been established by RAD Intel.

OpenAI backs startup aiming to block AI-enabled bioweapons

SAN FRANCISCO -ChatGPT maker OpenAI on Thursday said it will invest in a startup focused on blocking bad actors from creating biological weapons powered by artificial intelligence.OpenAI is the lead investor in a $15 million seed round in Red Queen Bio, which is trying to make sure the AI industry’s defenses …

Savage: The 60/40 Portfolio Is No Longer Viable [sponsor]
For years, retirement investors were advised to rely on the 60/40 strategy. That’s no longer the case. Michael Savage highlights that this model has become obsolete—now even Morgan Stanley incorporates gold and silver into its updated asset allocation. With gold soaring 45% this year, exceeding $3,800, the moment to act is unmistakable. Secure your complimentary Precious Metals Playbook today and discover how to safeguard your retirement savings. Claim Your Complimentary Precious Metals Playbook Now!

This simple trade happens 3-5x’s a week, Options expert shares his strategy. [sponsor]

Urgent: Trump’s 90-Day Window for Crypto Wealth [sponsor]

Washington Insider – This Could be Trump’s Social Security Fix [sponsor]

DISCLAIMER
This is a paid advertisement for informational and educational purposes only and does not constitute financial advice. Investing involves risk and may not be suitable for all individuals. Past performance does not guarantee future results.
Trading Stocks Now is operated by Investing Media Solutions, LLC. We are not licensed financial advisors. Always consult with a certified financial professional before making investment decisions.

IMPORTANT NOTICE AND DISCLAIMER
Investing Media Solutions, LLC (“IMS”), the owner of this website (the “Website”), cannot guarantee the accuracy or completeness of the information contained in any article, email, newsletter, or other publication posted on or viewed in connection with this website (the “Publications”). The author or authors of those Publications are solely responsible for their contents. IMS has not done any research or due diligence into the markets, industries, or companies which may appear or be mentioned in the Publications. IMS will NOT be liable for any loss or damage caused by a reader’s reliance on information posted on the Website or contained in the Publications.

FOR EDUCATIONAL AND INFORMATIONAL PURPOSES ONLY; NOT INVESTMENT ADVICE.
This Website and the Publications are for educational and informational purposes only. This Website and the Publications do not purport to be a complete analysis of any company’s financial position. This Website, the Publications or any statements made in the Publications are not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular individual.This Website or the statements made in the Publications should NOT be relied upon for purposes of transacting in any securities posted on the Website or mentioned in the Publications, nor should they be construed as a personalized recommendation to you to buy, sell, or hold any position in any security posted on this Website or mentioned in any Publications.b>

SUBSTANTIAL RISK IN INVESTMENT.
Any individual who chooses to invest in any securities including those mentioned in the Publications should do so with caution.Investing or transacting in securities involves substantial risk; you may lose some, all, or possibly more than your original investment.Readers bear responsibility for their own investment research and decisions and should review all investment decisions with a licensed or registered investment professional.

NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER
Neither IMS nor any of its respective owners or employees are registered or licensed as a securities broker-dealer, broker, an investment advisor, or an investment advisor representative with the U.S. Securities and Exchange Commission (SEC), any state securities regulatory authority, or any self-regulatory organization.

For full policies, see our: Disclaimer | Privacy | Terms

Trading Stocks Now
203 N La Salle Street, Suite 2100 | Chicago, IL 60601

unsubscribe

Fed hopes melt, stocks sink

In Today’s News

New Amazon Crisis Could Tank U.S. Stock Market [sponsor]

Fitch downgrades Aston Martin’s ratings as US demand uncertain

Fed hopes melt, stocks sink

Pfizer slashes stake in COVID vaccine partner BioNTech

OpenAI backs startup aiming to block AI-enabled bioweapons

You Might Also Like

This simple trade happens 3-5x’s a week, Options expert shares his strategy. [sponsor]

Urgent: Trump’s 90-Day Window for Crypto Wealth [sponsor]

Washington Insider – This Could be Trump’s Social Security Fix [sponsor]

More From Author

OpenAI backs startup aiming to block AI-enabled bioweapons

Pfizer slashes stake in COVID vaccine partner BioNTech

Fed hopes melt, stocks sink

OpenAI backs startup aiming to block AI-enabled bioweapons

Live Market Pulse

Recent Posts

Categories

In Today’s News

You Might Also Like

Live Market Pulse

Sign up for our free Trading Stocks Now Newsletter!

Recent Posts

Categories